Trial intelligence / Profile preview

Pharmacokinetic and pharmacodynamic assessment of mycophenolic acid in kidney transplant recipients

2005-006162-33Phase 2Completed

Sponsor
Roche
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of mycophenolic acid in kidney transplant, sponsored by Roche. Primary endpoint: Correlation between pharmacokinetic and pharmacodynamic parameters. Started Aug 2006; status: completed.

02

Drugs

mycophenolic acid
03

Conditions

kidney transplant

Beyond the preview

Go deeper on 2005-006162-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-006162-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call